How to Get Rid of Fatty Liver: What Actually Works

Losing about 5 to 10 percent of your body weight through diet and exercise is the single most effective way to reverse fatty liver disease, and it remains the foundation of every clinical guideline on the topic. That said, the landscape has shifted in recent years with the approval of the first targeted medication and strong trial results for drugs originally designed for diabetes. What works depends partly on how far the disease has progressed and whether you are dealing with simple fat accumulation or the more dangerous inflammatory stage.

Weight Loss Thresholds That Actually Matter

Not all weight loss is created equal when it comes to your liver. Research consistently points to specific cutoffs. Losing at least 5 percent of your body weight tends to reduce liver fat and improve liver enzyme levels. But the real payoff comes at the 10-percent mark: in one key study, every participant who lost that much saw improvement, with about 90 percent achieving resolution of the inflammatory form of the disease (called NASH or MASH, depending on which naming system you encounter) and 45 percent showing reversal of scarring. The catch is that only about 10 percent of participants in that study managed to lose that much weight and keep it off.¹

This is the core frustration with fatty liver treatment: the intervention that works best is the one most people struggle to sustain. That reality has driven interest in medications and surgical options, especially for people with more advanced disease. But if you can get to that 7 to 10 percent range of sustained weight loss through any safe method, the liver tends to respond well.

What Kind of Diet Works Best

There is no single “fatty liver diet,” but the Mediterranean pattern has the strongest evidence. A crossover trial comparing a traditional Mediterranean diet to a low-fat, high-carbohydrate diet found that the Mediterranean approach cut liver fat by about 39 percent over six weeks, compared to just 7 percent on the low-fat plan.² The Mediterranean diet emphasizes olive oil, nuts, fish, vegetables, and whole grains while limiting added sugars and refined carbohydrates. That composition appears to help not just through calorie reduction but by changing the types of fat the liver stores. Research shows that the composition of fat in the liver matters: saturated fat within liver cells is more closely linked to insulin resistance than total fat content is, and diets that shift the balance toward unsaturated fats appear to be protective.³

Intermittent fasting has also shown promise. A randomized trial comparing a 5:2 fasting schedule (eating normally five days, restricting calories two days) to daily calorie restriction found that the fasting group had notably better outcomes. Fewer than a third of the fasting group still had moderate or worse fatty liver at the end of the study, compared to nearly 60 percent in the daily restriction group. Liver stiffness, a marker of scarring, was also lower in the fasting group.⁴ This does not mean intermittent fasting is definitively superior to all other dietary approaches, but it suggests that for some people it may be easier to stick with and still deliver strong liver benefits.

What to cut is at least as important as what to add. Sugar-sweetened beverages and foods high in fructose are particularly harmful because fructose drives the liver to create new fat through a process that directly worsens insulin resistance.⁵ If you change nothing else about your diet, cutting out sugary drinks and reducing processed food is a reasonable starting point.

Exercise Helps Even Without Weight Loss

One of the more encouraging findings in fatty liver research is that exercise reduces liver fat independently of what the scale says. A meta-analysis pooling data from multiple trials found that exercise without significant weight loss still produced a meaningful reduction in liver fat content. Both aerobic exercise on its own and combinations of aerobic and resistance training were effective.⁶ An earlier study confirmed this directly: four weeks of aerobic cycling reduced liver fat by about 21 percent and visceral belly fat by about 12 percent in obese adults, with no change in body weight at all.⁷

This matters because many people get discouraged when the number on the scale does not budge. Your liver can still be improving. The mechanism likely involves exercise burning off visceral fat and improving how your muscles use insulin, which reduces the flood of fatty acids reaching the liver. Resistance training adds its own benefits by lowering cholesterol and triglycerides. The takeaway is that any regular physical activity you can maintain is worth doing, whether or not it leads to visible weight loss.

Coffee as a Protective Factor

This is one of the more consistent and frankly pleasant findings in liver research: coffee drinkers have less liver scarring. Two separate meta-analyses of observational studies found that people with fatty liver disease who drank coffee had roughly 30 percent lower risk of fibrosis compared to non-drinkers.⁸⁹ A separate study found that drinking two or more cups a day was associated with lower liver stiffness regardless of the type of liver disease.¹⁰

These are observational findings, so they cannot prove causation. People who drink coffee may differ from non-drinkers in other ways. But the association is strong enough and consistent enough across studies that most hepatologists consider moderate coffee consumption a reasonable habit for people with fatty liver. The benefit appears to come from compounds in coffee beyond caffeine, including polyphenols and diterpenes that reduce inflammation and oxidative stress. There is no reason to start drinking coffee solely for your liver if you do not already enjoy it, but if you do, there is no reason to stop.

Medications for More Advanced Disease

For decades, there was no FDA-approved drug for fatty liver disease. That changed in March 2024 with the accelerated approval of resmetirom, a pill that targets a specific thyroid hormone receptor in the liver.¹¹ It is approved for adults with the inflammatory form of the disease (MASH) who have moderate to advanced scarring but not yet cirrhosis. In its pivotal trial, about 26 to 30 percent of patients taking resmetirom achieved resolution of liver inflammation without worsening of scarring, compared to roughly 10 percent on placebo. About a quarter saw their fibrosis improve by at least one stage.¹² Resmetirom also lowered LDL cholesterol by about 12 to 14 percent, which matters because heart disease, not liver failure, is the leading cause of death in people with fatty liver.¹³

The numbers may sound modest, but context matters. These patients already had significant scarring, and the disease was progressing. A drug that reverses inflammation in roughly a third of cases and improves scarring in a quarter represents a real step forward for a disease that previously had no pharmacological option beyond managing risk factors.

GLP-1 and Dual-Action Drugs

Tirzepatide, a drug already approved for type 2 diabetes and weight loss, has shown striking results for fatty liver in a phase 2 trial. At the highest dose tested, 62 percent of participants achieved resolution of liver inflammation without worsening fibrosis, compared to 10 percent on placebo. About half saw improvement in fibrosis by at least one stage.¹⁴ Animal studies suggest that tirzepatide reduces liver fat accumulation by altering how the liver takes up fatty acids.¹⁵ These numbers are substantially better than what resmetirom achieved, though the comparison is imperfect since the trials enrolled somewhat different populations and tirzepatide also causes significant weight loss, which itself drives liver improvement.

Semaglutide, the active ingredient in Ozempic and Wegovy, is being studied along similar lines, though the trial data specifically for liver endpoints has been more mixed. The broader GLP-1 class is widely expected to become a major treatment option for fatty liver in the coming years, largely because these drugs address the metabolic root causes: insulin resistance, excess body fat, and inflammation.

SGLT2 Inhibitors

SGLT2 inhibitors, another class of diabetes drugs, have also been investigated. A meta-analysis found they improve liver function markers, reduce body weight by about 2.7 kilograms on average, and improve cholesterol and blood sugar measures in patients with fatty liver, particularly those who also have type 2 diabetes.¹⁶ However, a separate meta-analysis looking specifically at patients without diabetes found that SGLT2 inhibitors did not significantly improve metabolic markers like triglycerides or blood sugar.¹⁷ The benefit appears to be concentrated in people who have both conditions.

When Surgery Becomes an Option

For people with severe obesity who have not been able to achieve sufficient weight loss through diet and exercise alone, bariatric surgery can produce dramatic improvements in fatty liver. A meta-analysis found that the proportion of patients with liver fat accumulation dropped by about 44 percent within three to six months of surgery, and inflammation continued to improve over the following years. Significant scarring decreased by about 18 percent at one to two years.¹⁸ Another analysis reported pooled remission rates of about 70 percent for liver inflammation and 57 percent for fibrosis after bariatric surgery, along with remission of type 2 diabetes in roughly 59 percent of patients.¹⁹

Surgery is not a first-line treatment for fatty liver on its own. It is considered when a person qualifies based on their obesity and related conditions. But the liver improvements are a major secondary benefit and, for some patients with progressive disease and severe obesity, may be the most reliable path to disease reversal.

Supplements and Unproven Remedies

Vitamin E is the supplement with the most research behind it for fatty liver. It reduces oxidative stress, which is one of the drivers of liver cell damage.²⁰ Some guidelines suggest it for people with biopsy-confirmed NASH who do not have diabetes, but its use remains controversial because long-term high-dose vitamin E has been linked to a small increase in prostate cancer risk and other concerns. It is not a blanket recommendation.

Milk thistle (silymarin) is one of the most commonly purchased liver supplements, but the evidence is mixed. A randomized trial found that silymarin did not meet its primary endpoint of overall improvement in liver disease activity. However, patients in the silymarin group did show significantly more reduction in fibrosis than the placebo group, and several fibrosis scoring tools improved in the treatment arm but not in the placebo arm.²¹ The mixed results mean that silymarin might have some anti-fibrotic effect, but it is not a proven treatment for fatty liver as a whole. Many other supplements marketed for “liver detox” or “liver cleanse” have essentially no rigorous evidence behind them.

Why Heart Disease Matters More Than You Think

Here is something that surprises many people when they are first diagnosed: the most common cause of death in people with fatty liver disease is not liver failure. It is cardiovascular disease.²² Fatty liver is increasingly understood as a systemic metabolic disorder, not just a liver problem. It is closely intertwined with insulin resistance, abnormal blood lipids, and chronic low-grade inflammation, all of which accelerate artery disease.²³

This reframes the treatment conversation. Managing your cholesterol, blood pressure, and blood sugar is not just about protecting your heart alongside your liver. It is about addressing the single biggest threat that fatty liver poses to your life. The lifestyle changes that improve fatty liver, regular exercise, a healthier diet, moderate weight loss, are the same ones that reduce cardiovascular risk. The medications that show the most promise for fatty liver, like tirzepatide and resmetirom, also improve cholesterol profiles. Everything points in the same direction.

Fatty Liver Without Obesity

About 10 to 20 percent of people with fatty liver disease are not overweight. This condition, sometimes called lean MASLD, tends to catch both patients and doctors off guard. Genetics play a larger role in these cases. Variants in the PNPLA3 gene, for example, roughly triple the risk of developing fatty liver in lean individuals, and the variant is more common among people with lean fatty liver than among those who are overweight with the same condition.²⁴ Another study in an Asian population found that specific PNPLA3 and SAMM50 gene variants were strongly associated with lean fatty liver, with the high-risk genotypes roughly tripling the odds of disease even after adjusting for body mass and metabolic syndrome.²⁵

If you are lean and diagnosed with fatty liver, the same lifestyle recommendations still apply: reduce sugar, exercise regularly, limit alcohol. But the weight-loss strategy that works so well for the majority may not be appropriate or sufficient for you. In these cases, addressing insulin resistance through diet quality, exercise, and potentially medication becomes the main lever. Genetic testing for PNPLA3 variants is not routine in clinical practice, but awareness that this condition exists helps prevent the false reassurance that a normal weight means a healthy liver.

How Fatty Liver Is Tracked Without a Biopsy

Liver biopsy used to be the only way to know how much fat, inflammation, and scarring your liver had. It is still the gold standard for research purposes, but in practice most people are now monitored with non-invasive tools. FibroScan, a device that measures liver stiffness using ultrasound-based technology, is widely used. Blood-based scoring systems like FIB-4 (which combines age, platelet count, and liver enzymes) offer a quick screening estimate of fibrosis risk.

These tools are good at ruling out advanced disease but less reliable at confirming it. One study found that FibroScan correctly identified only about 46 percent of patients with biopsy-confirmed advanced scarring, though it was much better at detecting severe fat accumulation.²⁶ The Enhanced Liver Fibrosis (ELF) blood test performed particularly well in a real-world study, with discrimination for predicting clinical outcomes that was comparable to, and in some cases slightly better than, actual biopsy staging.²⁷ Many clinicians now use a two-step approach: an initial FIB-4 blood score to screen, followed by FibroScan or ELF if the score is elevated.

For practical purposes, these tools are good enough to guide treatment decisions for most people. If your non-invasive tests suggest low fibrosis risk, periodic monitoring with lifestyle changes is reasonable. If they suggest moderate or advanced fibrosis, a specialist referral and potentially a biopsy or advanced imaging become more important.

Sleep Apnea and the Liver

Obstructive sleep apnea has an underappreciated link to fatty liver. The repeated drops in oxygen during sleep promote insulin resistance and drive fat accumulation in the liver through pathways that operate independently of obesity.²⁸ If you snore heavily, feel exhausted despite seemingly adequate sleep, or have been told you stop breathing at night, getting evaluated for sleep apnea could be an overlooked part of addressing your fatty liver. Treating sleep apnea with CPAP or other interventions reduces the chronic oxygen deprivation that may be contributing to your liver condition.

Fatty Liver in Children and Teenagers

Fatty liver disease is now the most common chronic liver condition in children, driven by the same combination of genetics, sugary diets, and sedentary habits that affects adults. However, the disease looks different under a microscope in children, with patterns of fat distribution and inflammation that are distinct from what is seen in adults. No medications are specifically approved for pediatric fatty liver, making lifestyle changes the only available approach. Cutting sugar-sweetened beverages and processed foods, combined with increased physical activity, is the current standard recommendation for affected children and adolescents. The urgency is real: a child diagnosed with fatty liver at age 12 faces decades of potential disease progression, and the earlier the trajectory is shifted, the better the long-term outlook.

The Gut Connection

Your gut and liver are connected by the portal vein, which carries blood directly from your intestines to your liver. This means that anything leaking through a compromised intestinal lining, including bacterial products and toxins, reaches the liver first. Research has established that intestinal barrier dysfunction and shifts in gut bacteria contribute to the progression of fatty liver disease. Certain gut bacteria produce alcohol as a byproduct of digesting food, and in people with an imbalanced microbiome, those levels can rise enough to contribute to liver inflammation even in someone who does not drink.²⁹ Immune responses triggered by bacterial products crossing into the liver promote the kind of chronic inflammation that pushes simple fatty liver toward the scarring stage.³⁰

There are no proven probiotic regimens for fatty liver at this point. But the gut connection helps explain why dietary quality matters beyond its effect on weight. A fiber-rich diet that supports a diverse gut microbiome may help protect the intestinal barrier, reducing the load of inflammatory signals reaching the liver. This is an active area of research, and specific probiotic or prebiotic treatments may eventually become part of the standard approach, but we are not there yet.